PCSK9 and atrial fibrillation: Similarly, platelets incubated with PCSK9, at the concentration found in the circulation of atrial fibrillation (AF) patients, increased platelet aggregation and platelet thromboxane B2 (TxB2) release [47], a marker of in vivo platelet activation [64].